A RANDOMIZED PROSPECTIVE COMPARISON OF INTERMITTENT METHOTREXATE, METHOTREXATE WITH LEUCOVORIN, AND A METHOTREXATE COMBINATION IN HEAD AND NECK-CANCER

被引:0
作者
DECONTI, RC [1 ]
SCHOENFELD, D [1 ]
机构
[1] EASTERN COOPERAT ONCOL GRP,MADISON,WI
关键词
D O I
10.1002/1097-0142(19810901)48:5<1061::AID-CNCR2820480502>3.0.CO;2-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1061 / 1072
页数:12
相关论文
共 39 条
[1]   DOSE-RELATED SYNERGISM OF CYTOSINE-ARABINOSIDE AND METHOTREXATE AGAINST MURINE LEUKEMIA-L1210 [J].
AVERY, TL ;
ROBERTS, D .
EUROPEAN JOURNAL OF CANCER, 1974, 10 (07) :425-429
[2]  
BERTINO JR, 1973, CANCER-AM CANCER SOC, V31, P1141, DOI 10.1002/1097-0142(197305)31:5<1141::AID-CNCR2820310515>3.0.CO
[3]  
2-R
[4]  
CAPIZZI RL, 1970, CANCER RES, V30, P1782
[5]  
CHU MY, 1968, BIOCHEM PHARMACOL, V17, P741
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]  
Cox DR, 1970, ANAL BINARY DATA, P87
[8]  
DECONTI RC, 1976, P AM ASSOC CANC RES, V17, P248
[9]  
DJERASSI I, 1968, P AM ASSOC CANC RES, V9, P18
[10]  
DJERASSI I, 1972, CANCER, V30, P22, DOI 10.1002/1097-0142(197207)30:1<22::AID-CNCR2820300105>3.0.CO